Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation

Circulation Journal

Volumn 73, Issue 11, 2009, Pages 2036-2041

  Ino, Yasushi ^a   Toyoda, Yasuaki ^a   Tanaka, Atsushi ^b   Ishii, Shuuta ^a   Kusuyama, Yoshio ^a   Kubo, Takashi ^b   Takarada, Shigeho ^b   Kitabata, Hironori ^b   Tanimoto, Takashi ^b   Mizukoshi, Masato ^b   Imanishi, Toshio ^b   Akasaka, Takashi ^b  

^a National Hospital Organization   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Prognosis; Restenosis; Sirolimus eluting stent; Stent fracture

Indexed keywords

RAPAMYCIN;

ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INJURY; HUMAN; IMPLANTATION; INCIDENCE; LONG TERM CARE; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROGNOSIS; RESTENOSIS; REVASCULARIZATION; STENT; STENT FRACTURE; SYSTOLE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MOTION; PROGNOSIS; PROSTHESIS FAILURE; SIROLIMUS;

EID: 73249121409     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0343     Document Type: Article

References (27)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al, for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773 - 1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al, for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315 - 1323.
3. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107: 2178 - 2180.
4. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, et al. Coronary restenosis after sirolimus-eluting stent implantation: Morphological description and mechanical analysis from a consecutive series of cases. Circulation 2003; 108: 257 - 260.
5. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004; 110: 3430 - 3434.
6. Cowley MJ. Drug-eeluting stent restenosis: Incidence, predictors, mechanisms, and treatment. J Intervent Cardiol 2006; 19: S47 - S53.
7. Sianos G, Hofma S, Ligthart JM, Saia F, Hoye A, Lemos PA, et al. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv 2004; 61: 111 - 116.
8. Mehrle A, Skelton T, Almonacid A. Stent fracture: An unusual cause of late restenosis after sirolimus-eluting stent placement. Catheter Cardiovasc Interv 2007; 69: 989 - 992.
9. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 2007; 69: 380 - 386.
10. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S. Stent fracture associated with drug-eluting stents: Clinical characteristics and implications. Catheter Cardiovasc Interv 2007; 69: 387 - 394.
11. Okumura M, Ozaki Y, Ishii J, Kan S, Naruse H, Matsui S, et al. Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation. Circ J 2007; 71: 1669 - 1677.
12. Yang TH, Kim DI, Park SG, Seo JS, Cho HJ, Seol SH, et al. Clinical characteristics of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009; 131: 212 - 216.
13. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, et al. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 2007; 100: 627 - 630.
14. Shaikh F, Maddikunta R, Djelmami-Hani M, Solis J, Allaqaband S, Bajwa T. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis? Catheter Cardiovasc Interv 2008; 71: 614 - 618.
15. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, et al. Frequency, predictors and outcome of stent fracture after sirolimuseluting stent implantation. Int J Cardiol 2009; 133: 321 - 326.
16. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344 - 2351.
17. Halkin A, Carlier S, Leon MB. Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosis. Heart 2004; 90: e45.
18. Kobayashi T, Shibata K, Yamamoto R, Mizobuchi M, Ono T, Funatsu A, et al. Three cases of stent fracture following Cypher stent implantation in the ostium of right coronary artery. Jpn J Interv Cardiol 2006; 21: 351 - 358.
19. Min PK, Yoon YW, Kwon HM. Delayed strut fracture of sirolimuseluting stent: A significant problem or an occasional observation? Int J Cardiol 2006; 106: 404 - 406.
20. Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S, et al. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: Immediate and long-term clinical and angiographic outcome. Circulation 2002; 105: 1883 - 1886.
21. Virmani R, Liistro F, Stankovic G, Mario CD, Montorfano M, Farb A, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 2002; 106: 2649 - 2651.
22. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004; 63: 617 - 624.
23. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: Three-year results of the RAVEL trial. Circulation 2005; 111: 1040 - 1044.
24. Cosgrave J, Corbett SJ, Melzi G, Babic R, Biondi-Zoccai GG, Airoldi F, et al. Late restenosis following sirolimus-eluting stent implantation. Am J Cardiol 2007; 100: 41 - 44.
25. Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, Kim YH, et al. Late target lesion revascularization after implantation of sirolimuseluting stent. Catheter Cardiovasc Interv 2008; 71: 299 - 303.
26. Suzuki S, Kamihata H, Hata T, Hayashi F, Miura A, Yoshinaga M, et al. Success rate of implantation and mid-term outcomes of the sirolimus-eluting stent. Circ J 2007; 71: 15 - 19.
27. Park JS, Shin DG, Kim YJ. Fractured DES with a patent coronary artery: Clinical implications. J Invasive Cardiol 2007; 19: E43 - E45.